Your energy is low, your metabolism has slowed, and hitting the gym doesnt deliver the results it used to
Supporting this, the SUSTAIN-6 cardiovascular outcomes trial found that once-weekly semaglutide drugs carry a higher risk of diabetic retinopathy progression
Weight loss injections, primarily glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and tirzepatide (Zepbound), work through multiple physiological mechanisms to promote weight reduction
Demographic Factors Certain groups of people are naturally more prone to anemia, and semaglutide use may exacerbate this risk
The same study also proved its safety for obese and overweight adults without diabetes, deeming it acceptable from both a patient and clinical perspective
Rybelsus tablets are taken once daily